Publicaciones en colaboración con investigadores/as de Hospital Universitario Nuestra Señora de Candelaria (28)

2023

  1. Association of Klotho with Coronary Artery Disease in Subjects with Type 2 Diabetes Mellitus and Preserved Kidney Function: A Case-Control Study

    International Journal of Molecular Sciences, Vol. 24, Núm. 17

  2. Associations between Inflammation, Hemoglobin Levels, and Coronary Artery Disease in Non-Albuminuric Subjects with and without Type 2 Diabetes Mellitus

    International journal of molecular sciences, Vol. 24, Núm. 18

  3. Klotho inversely relates with carotid intima- media thickness in atherosclerotic patients with normal renal function (eGFR ≥60 mL/min/1.73m2): a proof-of-concept study

    Frontiers in Endocrinology, Vol. 14

2022

  1. Klotho expression in peripheral blood circulating cells is associated with vascular and systemic inflammation in atherosclerotic vascular disease

    Scientific Reports, Vol. 12, Núm. 1

  2. RICORS2040: The need for collaborative research in chronic kidney disease

    Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387

  3. Repurposing drugs for highly prevalent diseases: pentoxifylline, an old drug and a new opportunity for diabetic kidney disease

    Clinical Kidney Journal, Vol. 15, Núm. 12, pp. 2200-2213

  4. Sodium-glucose co-transporter-2 inhibitors increase Klotho in patients with diabetic kidney disease: A clinical and experimental study

    Biomedicine and Pharmacotherapy, Vol. 154

2021

  1. Extracellular water/total body water ratio as predictor of mortality in hemodialysis patients

    Renal Failure, Vol. 43, Núm. 1, pp. 821-829

  2. Klotho as a biomarker of subclinical atherosclerosis in patients with moderate to severe chronic kidney disease

    Scientific Reports, Vol. 11, Núm. 1

2020

  1. Association between serum levels of Klotho and inflammatory cytokines in cardiovascular disease: a case-control study

    Aging, Vol. 12, Núm. 2, pp. 1952-1964

  2. Inflammatory Cytokines in Diabetic Kidney Disease: Pathophysiologic and Therapeutic Implications

    Frontiers in Medicine, Vol. 7

  3. Inflammatory targets in diabetic nephropathy

    Journal of Clinical Medicine, Vol. 9, Núm. 2

2019

  1. A Novel Heterozygous Deletion Variant in KLOTHO Gene Leading to Haploinsufficiency and Impairment of Fibroblast Growth Factor 23 Signaling Pathway

    Journal of Clinical Medicine, Vol. 8, Núm. 4, pp. 500

  2. Fibroblast growth factor 23 expression in human calcified vascular tissues

    Aging, Vol. 11, Núm. 18, pp. 7899-7913

  3. Pentoxifylline for renal protection in diabetic kidney disease. A model of old drugs for new horizons

    Journal of Clinical Medicine, Vol. 8, Núm. 3

2018

  1. Effects of pentoxifylline on soluble klotho concentrations and renal tubular cell expression in diabetic kidney disease

    Diabetes Care, Vol. 41, Núm. 8, pp. 1817-1820

  2. Phenotypic modulation of cultured primary human aortic vascular smooth muscle cells by uremic serum

    Frontiers in Physiology, Vol. 9, Núm. FEB

2017

  1. Anti-inflammatory profile of paricalcitol in kidney transplant recipients

    Nefrologia, Vol. 37, Núm. 6, pp. 622-629

  2. Soluble levels and endogenous vascular gene expression of KLOTHO are related to inflammation in human atherosclerotic disease

    Clinical Science, Vol. 131, Núm. 21, pp. 2601-2609

2016

  1. Effect of Paricalcitol on FGF-23 and Klotho in Kidney Transplant Recipients

    Transplantation, Vol. 100, Núm. 11, pp. 2432-2438